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Metagenome: differences in the gut microbiota among healthy, obese and type 2 
diabetes adults 
ABSTRACT 
The association between gut microbiota composition with pathogenesis of metabolic diseases 
namely obesity and type 2 diabetes are increasingly recognized. The aim of the study was to 
identify the diversity of gut microbiota phylum and families in the gut of healthy, obese and 
type 2 diabetes adults with metagenomic approach. Six healthy subjects, five obese subjects 
and five type 2 diabetes subjects of similar inclusion and exclusion criteria were recruited. 
The different bacterial phyla and families in the stool sample were analyzed with 
metagenomic analysis. The median (IQR)% of relative abundance for each phylum and 
families were analyzed. The obese subjects had higher Bacteroidetes 63.50(21.55)% with 
lower Firmicutes 27.00(13.55)%, meanwhile, the type 2 diabetes subjects also had higher 
Bacteroidetes 66.50(39.00)% with lower Firmicutes 27.70(19.35)%. These findings shows 
that there are differences in the gut microbiota composition in the healthy, obese and type 2 
diabetes adults which may influence the development of obesity and type 2 diabetes. 
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